Reata Pharmaceuticals (NASDAQ:RETA) – Moore Kuehn, PLLC encouraged

Reata Pharmaceuticals (NASDAQ:RETA) – Moore Kuehn, PLLC encouraged

Facebook
Twitter
LinkedIn

NEW YORK, Sept. 12, 2022 (GLOBE NEWSWIRE) — Moore Kuehn, PLLC, a Wall Street-based securities law firm, is investigating whether certain officers and directors of Reata Pharmaceuticals, Inc. LETTER breached their fiduciary duties to shareholders. The investigations concern possible self-dealing. Shareholders may be entitled to damages and corporate governance reforms.

If you own LETTER please contact Justin Kuehn, Esq. by email at [email protected] or by calling (212) 709-8245. The consultation and the case are free of charge and non-binding for you. Moore Kuehn covers all case costs and does not charge any fees to its investor clients. Shareholders should contact the company immediately as the time to enforce your rights may be limited.

Moore Kuehn is a 5-star Google customer-rated New York City law firm dedicated to attorneys representing investors and consumers in disputes relating to securities laws, fraud, breach of fiduciary duty and other claims. For more information about Moore Kuehn, see http://www.moorekuehn.com/practice/new-york-securities-litigation/.

attorney advertising. Previous results do not guarantee similar results.

Moore Kuehn, PLLC
Justin Kuehn, Esq.
30 Wall Street, 8th floor
New York, New York 10005
[email protected]
(212) 709-8245



Read full story here https://www.benzinga.com/pressreleases/22/09/g28830811/moore-kuehn-pllc-encourages-investors-of-reata-pharmaceuticals-inc-to-contact-law-firm

More to explorer

Understanding Key Factors in Accidents

[ad_1] Pedestrian Safety Statistics Pedestrian safety is an urgent concern worldwide, with over 1.3 million people dying in traffic accidents annually. Pedestrians